Physician profile
Samir Taneja
NPI 1386638187
$37,765.50
in general payments reported to CMS, 2019-2025
16 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,665 · 2020: $4,000 · 2021: $2,600 · 2022: $1,612 · 2023: $11K · 2024: $368 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Consulting Fee: $11K · Food and Beverage: $1,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,467.30 |
| Consulting Fee | $10,772.50 |
| Food and Beverage | $1,649.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,817.40 | 2025 | General - Therapies, General - Kidney Stone Disease |
| Edap Technomed INC | $10,866.10 | 2023 | |
| Insightec,INC | $7,500.00 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $2,600.00 | 2021 | |
| Janssen Scientific Affairs, LLC | $2,157.61 | 2019-2025 | Balversa, Erleada |
| Janssen Biotech, INC. | $1,430.00 | 2022 | |
| Procept Biorobotics Corporation | $335.63 | 2023 | Aquabeam Robotic System |
| Intuitive Surgical, INC. | $183.00 | 2024-2025 | |
| Palette Life Sciences, INC. | $181.56 | 2022 | |
| Ferring Pharmaceuticals INC. | $164.46 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $149.70 | 2024 | |
| Abbvie INC. | $138.30 | 2023-2024 | Botox |
| Agiliti Surgical, INC. | $98.33 | 2023 | Cryocare Cs |
| Biotissue Holdings INC. | $95.00 | 2019 | |
| Urogen Pharma, INC. | $25.58 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.83 | 2023 | Endo Clip III |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Taneja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.